The analyst team at UBS has been hard at work this week analysing the deluge of profit reports which have come out, and have issued a number of buy recommendations on companies.

I’ve selected three of those which UBS believes will perform particularly well from a share price perspective, which I’ll run through now.

Let’s have a look.

Zip Co Ltd (ASX: ZIP)

Zip on Thursday announced record cash EBTDA of $268.9 million, up 57.9% on the previous year.

The buy now, pay later provider said total transaction volume (TTV) grew to $16.7 billion, up 27.2%, while the number of merchants on its platforms increased 13.8%.  

On the outlook, Chief Executive Officer Cynthia Scott said the company was targeting cash earnings of $340 million in FY27, which would be a 26% increase.

UBS said in a note to clients that the outlook for the current year was better than expected, providing comfort around the defensive qualities of the buy now, pay later business model through slowing economic times.

UBS said:

Whilst macro remains key uncertainty into FY27, we have increased confidence around Zip’s defensive quality and ability to drive customer growth and transaction frequency. Our US TTV growth forecast of +30% in FY27 is comprised of 9% customer growth and 19% TTV/customer growth, which we view achievable.

UBS has a price target on ZIP shares of $4.70 compared to $2.76 currently.

Megaport Ltd (ASX: MP1)

This cloud computing company this week announced FY26 revenue of $312.2 million, up 37%, while EBITDA was up 24% to $77.1 million.

Megaport Chief Executive Officer Michael Reid said:

Our team delivered an exceptional result in FY26. The Network business produced its strongest commercial performance to date, Latitude.sh expanded rapidly following acquisition, and our combined capabilities secured major long-term customer contracts across Compute, Network, and Storage. We have materially increased the scale of the business, broadened the markets we can serve, and created a much larger opportunity. Now our job is to execute against it.

UBS said the net outcome of the results report was “firmly in the positive”, and they are estimating EBITDA of $624 million for Megaport in FY28.

The broker has a price target of $26.40 on Megaport shares, up from $24.20, compared to the current share price of $18.60.

MA Financial Group Ltd (ASX: MAF)

UBS said MA Financial Group delivered an in-line FY26 result, “though we think the share price reaction (+18%) reflects material potential for upside towards new FY29 targets, and a stronger 2H outlook”.

UBS has a price target on MA Financial Group of $10.10 compared to $7.07 currently.

The post 3 ASX shares UBS says will return better than 36% appeared first on The Motley Fool Australia.

More reading

• How high do UBS and Macquarie think Zip shares will go?
• Buy, hold, sell: Fortescue, Northern Star, and Megaport shares
• Here are the top 10 ASX 200 shares today
• 7 ASX 200 shares with reaffirmed buy ratings this week
• Buy, sell, hold: Dexus, APA, Zip shares

Motley Fool contributor Cameron England has positions in Megaport. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Megaport. The Motley Fool Australia has recommended Ma Financial Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Guzman Y Gomez (ASX: GYG), Pro Medicus Ltd (ASX: PME), and James Hardie Industries PLC (ASX: JHX) shares are making waves today.

Two of the big name ASX shares are outpacing the 0.2% losses posted by the S&P/ASX 200 Index (ASX: XJO) in late morning trade on Friday, while one is charging higher.

Here’s what’s grabbing investor interest.

James Hardie shares lift on $1.4 billion asset sale

James Hardie shares are in the green today, up 0.6% at $43.05 apiece.

Investors are responding positively after the ASX 200 building materials company announced that it is divesting its European operations.

The company will sell its Fermacell business to Holcim for €840 million (AU$1.38 billion). James Hardie also intends to close its European fibre cement operations.

The ASX 200 stock will use the proceeds to pay down some $600 million in debt as well as funding a new $250 million share buyback. The company expects the deal to close in the first half of calendar 2027.

Commenting on the sale helping lift James Hardie shares today, CEO Aaron Erter said:

We believe this divestiture will strengthen our balance sheet, deliver compelling value for our shareholders and position the Fermacell business for long-term success under Holcim’s ownership.

Guzman Y Gomez shares jump on earnings surge

Like James Hardie shares, Guzman Y Gomez shares are outperforming today.

And strongly.

At the time of writing, shares in the ASX 200 Mexican fast-food restaurant chain are up 8%, changing hands for $25.89 each.

This follows the release of Guzman Y Gomez’s full-year FY 2026 results.

Investors look to be supporting the stock, with GYG now having completed its painful exit from its US operations and eying growth in its core Aussie markets.

While GYG achieved a statutory net profit after tax (NPAT) increase of 31.6% from FY 2025 to $40.6 million, the company reported a statutory group NPAT loss of $26.7 million due to its US exit.

In other core financial metrics, Guzman Y Gomez shares are likely attracting attention, with the company reporting a 28.7% year-on-year increase in underlying earnings before interest, taxes, depreciation and amortisation (EBITDA) to $85 million.

Management also announced an additional $100 million share buyback.

Which brings us to…

Pro Medicus shares slide despite new contract win

Joining Guzman Y Gomez and James Hardie shares in turning heads today, we find Pro Medicus.

At the time of writing, shares in the ASX 200 health imaging company are down 3.1%, trading for $199.71 apiece.

Pro Medicus shares are sliding despite the company announcing a new $25 million, seven-year contract with United States-based healthcare provider Valley Health. The contract covers the full range of Pro Medicus’ cloud-based medical imaging solutions.

The post Why Guzman Y Gomez, Pro Medicus and James Hardie shares are turning heads on Friday appeared first on The Motley Fool Australia.

More reading

• Pro Medicus signs A$25m US contract: What it means for investors
• Guzman y Gomez delivers record FY26 results, launches new buyback
• James Hardie sells European business, launches share buyback
• Investing in AI stocks on the ASX? Here’s what you should buy
• My top 5 ASX 200 shares to buy and hold

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Global Lithium Resources Ltd (ASX: GL1) shares have jumped substantially in recent weeks, as the company has secured key approvals for its Manna lithium project in Western Australia.

The shares are up slightly more than 200% over the past 12 months, but the analyst team at Shaw and Partners believe the share price has a long way to go yet.

They’ve got a buy rating on the shares, and a very bullish share price target, which I’ll get to shortly.

First, let’s look at the company’s recent announcements.

Approvals coming thick and fast

Firstly, in early August, GL1 announced that it had received approval for the Mining Development and Closure Proposal (MDCP).

The company said at the time:

The approved MDCP enables the establishment of important early works and critical infrastructure at the Manna mine site, directly supporting the integrated Manna-Nova strategy. The proposed Manna mine, located 110km east of Kalgoorlie-Boulder, is planned to operate for at least 14 years. The Project’s MDCP approval contemplates the development of multiple open pits, comprising one main (Manna Main) and two satellites (Manna North and Manna South), waste rock and dry stack tailings, ore stockpiles, accommodation village, bore field, topsoil stockpile areas and associated mining infrastructure.

The company said the approval would also give more confidence to a final investment decision for the mine, which is targeted for the fourth quarter of 2026, with the first direct shipping ore then targeted for the second quarter of 2027.

Then on 20 August, GL1 announced it had received the Native Vegetation Clearing Permit for the mine, completing the primary state approvals needed to begin early works. The company’s groundwater licence was also approved.

GL1 Managing Director Dr Dianmin Chen said:

Three major approvals in a fortnight is a credit to the professionalism of DMPE and DWER and to the depth of our own team’s technical work. Manna is now cleared on the ground, cleared to take water, and ready to move into construction. These approvals pave the way for starting early works and then mining operations at Manna, which will generate jobs, boost economic activity in the region, and benefit all stakeholders including our local communities for many years to come.

Global Lithium Resources shares looking cheap

Shaw and Partners said GL1 had substantially derisked the Manna project by securing the approvals.

The broker added:

Instead of committing to a standard greenfield build, GL1 management’s capital-light approach has successfully preserved Manna’s cash and strategic optionality. This positions Manna to capture the near-term market window, where lithium prices are expected to benefit from sustained supply deficits and growing demand over the next three years.

Shaw and Partners has a price target of $1.75 on GL1 shares, compared to 67.5 cents currently.

The post Up more than 200% over a year, could this ASX lithium company double again? appeared first on The Motley Fool Australia.

More reading

• What ASX reporting season share price swings really mean
• How high do UBS and Macquarie think Zip shares will go?
• Why is the Bitcoin price rocketing 16% this week?
• Buy, hold, sell: Fortescue, Northern Star, and Megaport shares
• Could this ASX portfolio make work optional at 55?

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.